To access this element change to forms mode OFF
Grant Award View - GA339100
The impact of Human T-lymphotropic Virus Type 1 on Indigenous...
GA ID:
GA339100
Agency:
Department of Health and Aged Care
Approval Date:
17-Sep-2020
Publish Date:
13-Oct-2023
Category:
Medical Research
Grant Term:
13-Oct-2020 to 31-Mar-2026
Value (AUD):
$4,950,000.00
(GST inclusive where applicable)
One-off/Ad hoc:
Yes
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 22/23 DoHAC 19/20 Health Output 2.2 Aboriginal and Torres Strait Islander Health
Grant Program:
Indigenous Australians Health Programme
Grant Activity:
The impact of Human T-lymphotropic Virus Type 1 on Indigenous Australians
Purpose:
The purpose of this grant is to support the Public Health Response to Human T-Lymphotropic Virus Type 1 in Australian Indigenous communities through research and to better understand the burden of disease associated with HTLV-1 in Indigenous communities.
GO ID:
GO Title:
The impact of Human T-lymphotropic Virus Type 1 on Indigenous Australians
Confidentiality - Contract:
No
Confidentiality - Outputs:
No
Grant Recipient Details
Recipient Name:
Baker Heart and Diabetes Institute
Recipient ABN:
98 131 762 948
Grant Recipient Location
Suburb:
Melbourne
Town/City:
Melbourne
Postcode:
3004
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NT
Postcode:
0872
Country:
AUSTRALIA